{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:04:27Z","timestamp":1792785867984,"version":"4.5.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002996","name":"Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Dutch Foundation","award":["2020B005"],"award-info":[{"award-number":["2020B005"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Dilated cardiomyopathy (DCM) is a major cause of heart failure impairing patient wellbeing and imposing a substantial economic burden on society, but respective data are missing. This study aims to measure the quality of life (QoL) and societal costs of DCM patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>A cross-sectional evaluation of QoL and societal costs of DCM patients was performed through the 5-level EuroQol and the Medical Consumption Questionnaire and Productivity Cost Questionnaire, respectively. QoL was translated into numerical values (i.e. utilities). Costs were measured from a Dutch societal perspective. Final costs were extrapolated to 1 year, reported in 2022 Euros, and compared between DCM severity according to NYHA classes. A total of 550 DCM patients from the Maastricht cardiomyopathy registry were included. Mean age was 61 years, and 34% were women. Overall utility was slightly lower for DCM patients than the population mean (0.840\u00a0vs. 0.869, P\u00a0=\u00a00.225). Among EQ-5D dimensions, DCM patients scored lowest in \u2018usual activities\u2019. Total societal DCM costs were \u20ac14\u2009843 per patient per year. Cost drivers were productivity losses (\u20ac7037) and medical costs (\u20ac4621). Patients with more symptomatic DCM (i.e. NYHA class III or IV) had significantly higher average DCM costs per year compared to less symptomatic DCM (\u20ac31\u2009099\u00a0vs. \u20ac11\u2009446, P\u00a0&amp;lt; 0.001) and significantly lower utilities (0.631\u00a0vs. 0.883, P\u00a0&amp;lt; 0.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>DCM is associated with high societal costs and reduced QoL, in particular with high DCM severity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjqcco\/qcad056","type":"journal-article","created":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T08:55:43Z","timestamp":1694595343000},"page":"334-344","source":"Crossref","is-referenced-by-count":10,"title":["Quality of life and societal costs in patients with dilated cardiomyopathy"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2608-2900","authenticated-orcid":false,"given":"Isabell","family":"Wiethoff","sequence":"first","affiliation":[{"name":"Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Maastricht University , 6200 MD Maastricht , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8165-6631","authenticated-orcid":false,"given":"Maurits","family":"Sikking","sequence":"additional","affiliation":[{"name":"Department of Cardiology, CARIM, Maastricht University Medical Centre , 6229 ER Maastricht , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1026-570X","authenticated-orcid":false,"given":"Silvia","family":"Evers","sequence":"additional","affiliation":[{"name":"Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Maastricht University , 6200 MD Maastricht , The Netherlands"},{"name":"Trimbos Institute, Netherlands Institute of Mental Health and Addiction, Centre for Economic Evaluation and Machine Learning , 3500 AS Utrecht , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7650-4534","authenticated-orcid":false,"given":"Andrea","family":"Gabrio","sequence":"additional","affiliation":[{"name":"Department of Methodology and Statistics, Faculty of Health Medicine and Life Science, Maastricht University , 6229 HA Maastricht , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6222-071X","authenticated-orcid":false,"given":"Michiel","family":"Henkens","sequence":"additional","affiliation":[{"name":"Department of Cardiology, CARIM, Maastricht University Medical Centre , 6229 ER Maastricht , The Netherlands"},{"name":"Department of Pathology, Maastricht University Medical Centre , 6229 HX Maastricht , The Netherlands"},{"name":"Netherlands Heart Institute (NLHI) , 3511 EP Utrecht , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6432-0431","authenticated-orcid":false,"given":"Michelle","family":"Michels","sequence":"additional","affiliation":[{"name":"Department of Cardiology , Thoraxcenter, Erasmus MC, 3000 CA Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5549-1298","authenticated-orcid":false,"given":"Job","family":"Verdonschot","sequence":"additional","affiliation":[{"name":"Department of Cardiology, CARIM, Maastricht University Medical Centre , 6229 ER Maastricht , The Netherlands"},{"name":"European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-Heart), Maastricht University Medical Centre , 6202 AZ Maastricht , The Netherlands"},{"name":"Department of Clinical Genetics, Maastricht University Medical Centre , 6202 AZ Maastricht , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9477-7803","authenticated-orcid":false,"given":"Stephane","family":"Heymans","sequence":"additional","affiliation":[{"name":"Department of Cardiology, CARIM, Maastricht University Medical Centre , 6229 ER Maastricht , The Netherlands"},{"name":"European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-Heart), Maastricht University Medical Centre , 6202 AZ Maastricht , The Netherlands"},{"name":"Department of Cardiovascular Research, University of Leuven , 3000 Leuven , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4274-9258","authenticated-orcid":false,"given":"Micka\u00ebl","family":"Hiligsmann","sequence":"additional","affiliation":[{"name":"Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Maastricht University , 6200 MD Maastricht , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,9,14]]},"reference":[{"key":"2024062010205642600_bib1","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0140-6736(16)31713-5","article-title":"Dilated cardiomyopathy","volume":"390","author":"Weintraub","year":"2017","journal-title":"Lancet"},{"key":"2024062010205642600_bib2","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/CIRCRESAHA.116.309396","article-title":"Dilated cardiomyopathy: genetic determinants and mechanisms","volume":"121","author":"McNally","year":"2017","journal-title":"Circ Res"},{"key":"2024062010205642600_bib3","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/CIRCGEN.120.003031","article-title":"Implications of genetic testing in dilated cardiomyopathy","volume":"13","author":"Verdonschot","year":"2020","journal-title":"Circ Genom Precis Med"},{"key":"2024062010205642600_bib4","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ejhf.1103","article-title":"Evolving concepts in dilated cardiomyopathy","volume":"20","author":"Merlo","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2024062010205642600_bib5","doi-asserted-by":"crossref","first-page":"l1570","DOI":"10.1136\/bmj.l1570","article-title":"Inherited cardiomyopathies","volume":"365","author":"Miles","year":"2019","journal-title":"BMJ"},{"key":"2024062010205642600_bib6","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/heart.83.6.645","article-title":"Health related quality of life and psychological wellbeing in patients with dilated cardiomyopathy","volume":"83","author":"Steptoe","year":"2000","journal-title":"Heart"},{"key":"2024062010205642600_bib7","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s12471-023-01776-1","article-title":"A systematic literature review of economic evaluations and cost-of-illness studies of inherited cardiomyopathies","volume":"31","author":"Wiethoff","year":"2023","journal-title":"Neth Heart J"},{"key":"2024062010205642600_bib8","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2165\/11588380-000000000-00000","article-title":"Cost-of-illness studies: a guide to critical evaluation","volume":"29","author":"Larg","year":"2011","journal-title":"Pharmacoeconomics"},{"key":"2024062010205642600_bib9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3350\/cmh.2014.20.4.327","article-title":"Cost-of-illness studies: concepts, scopes, and methods","volume":"20","author":"Jo","year":"2014","journal-title":"Clin Mol Hepatol"},{"key":"2024062010205642600_bib10","first-page":"100089","article-title":"Healthcare resource utilization and cost of obstructive hypertrophic cardiomyopathy in a US population","volume":"13","author":"Butzner","year":"2022","journal-title":"Am Heart J Plus"},{"key":"2024062010205642600_bib11","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1080\/13696998.2021.1978242","article-title":"Clinical and economic burden of obstructive hypertrophic cardiomyopathy in the United States","volume":"24","author":"Jain","year":"2021","journal-title":"J Med Econ"},{"key":"2024062010205642600_bib12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s40119-022-00257-7","article-title":"Treatment changes, healthcare resource utilization, and costs among patients with symptomatic obstructive hypertrophic cardiomyopathy: a claims database study","volume":"11","author":"Owens","year":"2022","journal-title":"Cardiol Ther"},{"key":"2024062010205642600_bib13","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12872-018-0815-3","article-title":"Cost-of-illness studies in heart failure: a systematic review 2004-2016","volume":"18","author":"Lesyuk","year":"2018","journal-title":"BMC Cardiovasc Disord"},{"key":"2024062010205642600_bib14","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s40273-020-00952-0","article-title":"A systematic review of medical costs associated with heart failure in the USA (2014-2020)","volume":"38","author":"Urbich","year":"2020","journal-title":"Pharmacoeconomics"},{"key":"2024062010205642600_bib15","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/ehf2.13833","article-title":"Improving diagnosis and risk stratification across the ejection fraction spectrum: the Maastricht Cardiomyopathy registry","volume":"9","author":"Henkens","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2024062010205642600_bib16","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","article-title":"Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases","volume":"37","author":"Pinto","year":"2016","journal-title":"Eur Heart J"},{"key":"2024062010205642600_bib17","author":"EuroQol Research Foundation","year":"2019"},{"key":"2024062010205642600_bib18","volume-title":"Manual iMTA Medical Cost Questionnaire (iMCQ)","author":"iMTA Productivity and Health Research Group","year":"2018"},{"key":"2024062010205642600_bib19","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jval.2015.05.009","article-title":"The iMTA productivity cost questionnaire: a standardized instrument for measuring and valuing health-related productivity losses","volume":"18","author":"Bouwmans","year":"2015","journal-title":"Value Health"},{"key":"2024062010205642600_bib20","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jval.2016.01.003","article-title":"Dutch tariff for the five-level version of EQ-5D","volume":"19","author":"Versteegh","year":"2016","journal-title":"Value Health"},{"key":"2024062010205642600_bib21","volume-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond","year":"2015"},{"key":"2024062010205642600_bib22","author":"Nederlandse Zorgautoriteit (NZa)"},{"key":"2024062010205642600_bib23","volume-title":"Passantenprijslijst DBC & OZP 2022 - Maastricht UMC+","author":"Maastricht University Medical Center (MUMC+)","year":"2022"},{"key":"2024062010205642600_bib24","article-title":"Costing Manual: Methodology of Costing Research and Reference Prices for Economic Evaluations in Healthcare","author":"Hakkaart-van Roijen","year":"; 2015"},{"key":"2024062010205642600_bib25","article-title":"Farmacotherapeutisch Kompas","author":"Zorginstituut Nederland (ZIN)","year":"2023"},{"key":"2024062010205642600_bib26","volume-title":"Guideline for Economic Evaluations in Healthcare","author":"National Health Care Institute","year":"2016"},{"key":"2024062010205642600_bib27","volume-title":"Consumer Prices 2022","author":"Centraal Bureau voor de Statistiek (CBS)"},{"key":"2024062010205642600_bib28","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/hrt.78.2.182","article-title":"Health related quality of life and psychological wellbeing in patients with hypertrophic cardiomyopathy","volume":"78","author":"Cox","year":"1997","journal-title":"Heart"},{"key":"2024062010205642600_bib29","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s10741-019-09890-2","article-title":"Quality of life of chronic heart failure patients: a systematic review and meta-analysis","volume":"25","author":"Moradi","year":"2020","journal-title":"Heart Fail Rev"},{"key":"2024062010205642600_bib30","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/europace\/euac011","article-title":"Long-term quality of life and acceptance of implantable cardioverter-defibrillator therapy: results of the European Heart Rhythm Association survey","volume":"24","author":"Januszkiewicz","year":"2022","journal-title":"Europace"},{"key":"2024062010205642600_bib31","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ahj.2008.04.029","article-title":"Predictors of improved quality of life 1 year after pacemaker implantation","volume":"156","author":"van Eck","year":"2008","journal-title":"Am Heart J"},{"key":"2024062010205642600_bib32","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1001\/archinte.167.20.2226","article-title":"Implantable cardioverter defibrillators and quality of life: results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study","volume":"167","author":"Passman","year":"2007","journal-title":"Arch Intern Med"},{"key":"2024062010205642600_bib33","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.recesp.2013.12.016","article-title":"Health care and nonhealth care costs in the treatment of patients with symptomatic chronic heart failure in Spain","volume":"67","author":"Delgado","year":"2014","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"2024062010205642600_bib34","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s12882-021-02548-y","article-title":"Patient, family and productivity costs of end-stage renal disease in the Netherlands; exposing non-healthcare related costs","volume":"22","author":"de Vries","year":"2021","journal-title":"BMC Nephrol"},{"key":"2024062010205642600_bib35","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/14737167.2019.1628641","article-title":"Quality of life and costs of patients prior to colorectal surgery","volume":"20","author":"Pattamatta","year":"2020","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"2024062010205642600_bib36","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s10198-021-01411-z","article-title":"The remarkably frequent use of EQ-5D in non-economic research","volume":"23","author":"Wang","year":"2022","journal-title":"Eur J Health Econ"},{"key":"2024062010205642600_bib37","article-title":"Questionnaires for the measurement of costs in economic evaluations","author":"Institute for Medical Technology Assessment (iMTA)","year":"2021"},{"key":"2024062010205642600_bib38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11886-021-01511-5","article-title":"Patient-reported outcomes in patients with cardiomyopathy","volume":"23","author":"Garcia","year":"2021","journal-title":"Curr Cardiol Rep"}],"container-title":["European Heart Journal - Quality of Care and Clinical Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjqcco\/advance-article-pdf\/doi\/10.1093\/ehjqcco\/qcad056\/51838181\/qcad056.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjqcco\/article-pdf\/10\/4\/334\/58285249\/qcad056.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjqcco\/article-pdf\/10\/4\/334\/58285249\/qcad056.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T06:22:18Z","timestamp":1718864538000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjqcco\/article\/10\/4\/334\/7274127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,14]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,9,14]]},"published-print":{"date-parts":[[2024,6,20]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjqcco\/qcad056","relation":{},"ISSN":["2058-5225","2058-1742"],"issn-type":[{"value":"2058-5225","type":"print"},{"value":"2058-1742","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,6]]},"published":{"date-parts":[[2023,9,14]]}}}